A Study Evaluating AMG 451 in Moderate To-severe Atopic Dermatitis (ROCKET-IGNITE)

    Not Recruiting
  • End date
    Jan 2, 2025
  • participants needed
  • sponsor
Updated on 20 July 2022
topical corticosteroid
topical agents


The purpose of this study is to evaluate the efficacy and safety of AMG 451 in monotherapy treatment.

Condition Atopic Dermatitis
Treatment Placebo, AMG 451
Clinical Study IdentifierNCT05398445
Last Modified on20 July 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note